Skip to main content
Berry Genomics Co.,Ltd logo

Berry Genomics Co.,Ltd — Investor Relations & Filings

Ticker · 000710 ISIN · CNE000000PN7 Shenzhen Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 2,009 across all filing types
Latest filing 2023-11-22 Transaction in Own Shar…
Country CN China
Listing Shenzhen Stock Exchange 000710

About Berry Genomics Co.,Ltd

https://www.berrygenomics.com

Berry Genomics Co.,Ltd. is a biotechnology enterprise specializing in clinical genomics and genetic testing services. The company focuses on the research, development, and commercialization of genomic technologies for clinical applications. Its core portfolio includes non-invasive prenatal testing (NIPT), utilizing high-throughput sequencing to screen for chromosomal abnormalities. Beyond reproductive health, the company provides genomic solutions for oncology diagnostics, including early cancer screening and companion diagnostics, as well as testing for hereditary diseases. Berry Genomics leverages advanced sequencing platforms and proprietary bioinformatics pipelines to deliver precision medicine tools to healthcare providers and research institutions. The company is recognized for its role in the clinical application of Next-Generation Sequencing (NGS) and its extensive genomic databases used to enhance diagnostic accuracy and therapeutic outcomes.

Recent filings

Filing Released Lang Actions
关于部分回购股份注销完成暨股份变动的公告
Transaction in Own Shares Classification · 100% confidence The document is an announcement regarding the completion of the cancellation of repurchased shares and the resulting change in the company's total share capital. It details the number of shares cancelled, the dates of relevant board and shareholder meetings approving the cancellation, and the impact on share capital structure. There is no financial statement or detailed financial analysis present. The document is focused on share repurchase and cancellation activities, which aligns with the category for company buying back or selling its own shares. The document length is under 5,000 characters and is a formal announcement of the share cancellation event, not a full financial report or earnings release. Therefore, the appropriate classification is Transaction in Own Shares (POS).
2023-11-22 Chinese
关于股票交易异常波动的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding abnormal stock price fluctuations for the company 成都市贝瑞和康基因技术股份有限公司. It details the investigation and findings related to the stock price movements, confirms no undisclosed material information, and provides risk warnings. The document is short (1185 characters) and does not contain financial statements or detailed financial data. It is a regulatory announcement about stock trading activity and compliance with disclosure rules, not a financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS).
2023-11-21 Chinese
关于注销部分回购股份及减少注册资本暨通知债权人的公告
Share Issue/Capital Change Classification · 95% confidence The document is an official announcement from a company regarding the cancellation of repurchased shares and the consequent reduction of registered capital. It also includes a notification to creditors about their rights to claim debts within a specified period. The content focuses on corporate actions related to share capital changes and creditor notifications, referencing relevant laws and company resolutions. The document length is short (1322 characters) and it is not a full financial report but a formal announcement of a corporate action. This fits the category of Share Issue/Capital Change (SHA), which covers announcements about share cancellations and capital changes.
2023-11-13 Chinese
第十届董事会第五次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the fifth meeting of the company's tenth board of directors. It includes details about the meeting date, attendance, and voting results on a specific agenda item regarding authorization to sell financial assets. There is no financial data, no detailed report, and no mention of a report being attached or published. The content focuses on board decisions and management authorization, which fits the category of Board/Management Information (MANG). The document length is short and it is clearly a meeting resolution announcement, not a full report or regulatory filing. Therefore, the classification is MANG with high confidence.
2023-11-13 Chinese
2023年第四次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a formal announcement of the resolutions passed at the company's 2023 fourth extraordinary general meeting of shareholders. It includes details about the meeting time, voting methods, attendance, and the voting results on specific proposals. It also contains a legal opinion confirming the validity of the meeting and its resolutions. The document does not contain financial statements or detailed financial analysis, nor is it a transcript or presentation. It is an official announcement of voting results from a shareholder meeting, which fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is short (2016 characters), and it is not merely announcing the availability of a report but providing the actual voting results and legal confirmation, so it is not a Report Publication Announcement (RPA). Therefore, the correct classification is DVA with high confidence.
2023-11-13 Chinese
北京市金杜律师事务所关于成都市贝瑞和康基因技术股份有限公司2023年第四次临时股东大会之法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the procedural legality and validity of a company's 2023 fourth extraordinary general meeting (临时股东大会). It details the convening, attendance, voting procedures, and results of the shareholders' meeting. The document does not contain financial statements or management discussion of financial results, nor is it an announcement of voting results in a brief form. Instead, it is a formal legal opinion on the meeting's compliance with laws and regulations. This type of document is best classified under Declaration of Voting Results & Voting Rights Announcements (DVA), as it relates to the official validation and announcement of shareholder meeting voting outcomes and procedures.
2023-11-13 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.